Drugs / CIGB-814
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07182656 | Aug 2025 → Apr 2026 overdue | rheumatoid arthritis | Yi Fang | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIGB-814 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07182656 ↗ |
| Route | Subcutaneous | “SC injection” NCT07182656 ↗ |